blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0799056

EP0799056 - USE OF A NK-1 RECEPTOR ANTAGONIST AND AN OPIOID ANALGESIC [Right-click to bookmark this link]
Former [1997/41]USE OF A TACHYKININ ANTAGONIST AND AN OPIOID ANALGESIC
[2001/15]
StatusNo opposition filed within time limit
Status updated on  31.01.2003
Database last updated on 31.08.2024
Most recent event   Tooltip06.08.2004Lapse of the patent in a contracting state
New state(s): LU		published on 22.09.2004  [2004/39]
Applicant(s)For all designated states
MERCK SHARP & DOHME LTD.
Hertford Road
Hoddesdon, Hertfordshire EN11 9BU / GB
[N/P]
Former [1997/41]For all designated states
MERCK SHARP & DOHME LTD.
Hertford Road
Hoddesdon Hertfordshire EN11 9BU / GB
Inventor(s)01 / HILL, Raymond, George
Terlings Park Eastwick Road
Harlow Essex CM20 2QR / GB
[1997/41]
Representative(s)Hiscock, Ian James, et al
European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road
Harlow, Essex CM20 2QR / GB
[N/P]
Former [1997/41]Hiscock, Ian James, et al
European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date95940386.615.12.1995
[1997/41]
WO1995GB02931
Priority number, dateGB1994002610223.12.1994         Original published format: GB 9426102
[1997/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9620009
Date:04.07.1996
Language:EN
[1996/30]
Type: A1 Application with search report 
No.:EP0799056
Date:08.10.1997
Language:EN
The application published by WIPO in one of the EPO official languages on 04.07.1996 takes the place of the publication of the European patent application.
[1997/41]
Type: B1 Patent specification 
No.:EP0799056
Date:27.03.2002
Language:EN
[2002/13]
Search report(s)International search report - published on:EP04.07.1996
ClassificationIPC:A61K45/06
[1997/41]
CPC:
A61K45/06 (EP,US); A61P25/04 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1997/41]
TitleGerman:VERWENDUNG VON NK-1 RECEPTOR ANTAGONISTEN MIT OPIOID-ANALGETIKA[2001/15]
English:USE OF A NK-1 RECEPTOR ANTAGONIST AND AN OPIOID ANALGESIC[2001/15]
French:UTILISATION D'UN ANTAGONISTE DU RECEPTEUR NK-1 ET D'UN ANALGESIQUE OPIOIDE[2001/15]
Former [1997/41]VERWENDUNG VON TACKYKININ-ANTAGONISTEN MIT OPIOID-ANALGETIKA
Former [1997/41]USE OF A TACHYKININ ANTAGONIST AND AN OPIOID ANALGESIC
Former [1997/41]UTILISATION D'UN ANTAGONISTE DE LA TACHYKININE ET D'UN ANALGESIQUE OPIOIDE
Entry into regional phase23.07.1997National basic fee paid 
23.07.1997Designation fee(s) paid 
23.07.1997Examination fee paid 
Examination procedure21.05.1996Request for preliminary examination filed
International Preliminary Examining Authority: EP
23.07.1997Examination requested  [1997/41]
25.05.2000Despatch of a communication from the examining division (Time limit: M06)
30.11.2000Reply to a communication from the examining division
16.03.2001Despatch of communication of intention to grant (Approval: No)
14.08.2001Despatch of communication of intention to grant (Approval: later approval)
10.09.2001Communication of intention to grant the patent
20.12.2001Fee for grant paid
20.12.2001Fee for publishing/printing paid
Opposition(s)30.12.2002No opposition filed within time limit [2003/12]
Fees paidRenewal fee
02.01.1998Renewal fee patent year 03
04.01.1999Renewal fee patent year 04
05.01.2000Renewal fee patent year 05
02.01.2001Renewal fee patent year 06
02.01.2002Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT27.03.2002
BE27.03.2002
CH27.03.2002
GR27.03.2002
LI27.03.2002
NL27.03.2002
DK27.06.2002
PT27.06.2002
SE27.06.2002
LU15.12.2002
IE16.12.2002
[2004/39]
Former [2004/01]AT27.03.2002
BE27.03.2002
CH27.03.2002
GR27.03.2002
LI27.03.2002
NL27.03.2002
DK27.06.2002
PT27.06.2002
SE27.06.2002
IE16.12.2002
Former [2003/45]AT27.03.2002
BE27.03.2002
CH27.03.2002
GR27.03.2002
LI27.03.2002
NL27.03.2002
DK27.06.2002
PT27.06.2002
SE27.06.2002
Former [2003/21]AT27.03.2002
BE27.03.2002
CH27.03.2002
GR27.03.2002
LI27.03.2002
NL27.03.2002
PT27.06.2002
SE27.06.2002
Former [2003/19]AT27.03.2002
BE27.03.2002
CH27.03.2002
GR27.03.2002
LI27.03.2002
NL27.03.2002
SE27.06.2002
Former [2003/16]AT27.03.2002
BE27.03.2002
CH27.03.2002
LI27.03.2002
NL27.03.2002
SE27.06.2002
Former [2003/09]AT27.03.2002
BE27.03.2002
NL27.03.2002
SE27.06.2002
Former [2003/06]BE27.03.2002
NL27.03.2002
SE27.06.2002
Former [2002/37]SE27.06.2002
Cited inInternational search[X]EP0533280  (GLAXO GROUP LTD [GB]) [X] 1* claims 1-3 *;
 [X]EP0615751  (GLAXO GROUP LTD [GB]) [X] 1 * claims 1-3 *;
 [X]  - TATTERSALL F D ET AL, "Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin-1 receptor antagonist CP-99,994", NEUROPHARMACOLOGY, 33 (2). 15-03-1994. 259-260., XP000570654 [X] 1-18 * abstract *

DOI:   http://dx.doi.org/10.1016/0028-3908(94)90018-3
 [X]  - BOUNTRA C ET AL, "Anti-emetic profile of a non-peptide neurokinin NK-1 receptor antagonist, CP-99,994, in ferrets", EUROPEAN JOURNAL OF PHARMACOLOGY, 249 (1). 1993. R3-R4., XP000571021 [X] 1-18 * abstract *

DOI:   http://dx.doi.org/10.1016/0014-2999(93)90673-6
Examination   - Maldonado R. et al.: Neuroscience Letters, 156 (1993), 135-140
    - Murtra P. et al.: Nature, 405 (2000), 180-183
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.